Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Lipodystrophy, Familial Partial

• Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
• Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
• A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)
• A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD)
• Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)
• Study of Gemcabene in Adults With FPLD
• CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy
• The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy
• Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
• Expanded Access Metreleptin Study